D J Kerr|W D Alexander - JoVE Visualize

Showing results (191-200 of 219) with videos related to

Pageof 22

Sort By:

European Journal of Cancer & Clinical Oncology|April 1, 1988

A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analoguesD Cunningham, C J Bradley, G J Forrest, et al.

Cancer Research|February 1, 1993

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusionD Bissett, A Setanoians, J Cassidy, et al.

Digestion|January 1, 1997

ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancerJ P Neoptolemos, D J Kerr, H Beger, et al.

British Journal of Cancer|October 1, 1994

Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinomaC S McArdle, D J Kerr, P O'Gorman, et al.

British Journal of Cancer|April 1, 1992

Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer. CRC Phase II Clinical Trials CommitteeS B Kaye, M Brampton, P Harper, et al.

International Journal of Oncology|June 4, 1998

A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinomaL W Seymour, S P Olliff, C J Poole, et al.

Biochimica Et Biophysica Acta|January 20, 1998

Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridinM J Cross, M N Hodgkin, J A Plumb, et al.

Lancet (London, England)|June 6, 2002

Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trialT S Maughan, R D James, D J Kerr, et al.

Nuclear Medicine Communications|December 1, 1987

Arteriovenous shunting of microspheres in patients with colorectal liver metastases: errors in assessment due to free pertechnetate, and the effect of angiotensin IIJ A Goldberg, M S Bradnam, D J Kerr, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998

Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancerC V Christodoulou, D R Ferry, D W Fyfe, et al.

Pageof 22

Showing results (191-200 of 219) with videos related to

Sort By:

Pageof 22

European Journal of Cancer & Clinical Oncology|April 1, 1988

A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analoguesD Cunningham, C J Bradley, G J Forrest, et al.

Cancer Research|February 1, 1993

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusionD Bissett, A Setanoians, J Cassidy, et al.

Digestion|January 1, 1997

ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancerJ P Neoptolemos, D J Kerr, H Beger, et al.

British Journal of Cancer|October 1, 1994

Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinomaC S McArdle, D J Kerr, P O'Gorman, et al.

British Journal of Cancer|April 1, 1992

Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer. CRC Phase II Clinical Trials CommitteeS B Kaye, M Brampton, P Harper, et al.

International Journal of Oncology|June 4, 1998

A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinomaL W Seymour, S P Olliff, C J Poole, et al.

Biochimica Et Biophysica Acta|January 20, 1998

Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridinM J Cross, M N Hodgkin, J A Plumb, et al.

Lancet (London, England)|June 6, 2002

Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trialT S Maughan, R D James, D J Kerr, et al.

Nuclear Medicine Communications|December 1, 1987

Arteriovenous shunting of microspheres in patients with colorectal liver metastases: errors in assessment due to free pertechnetate, and the effect of angiotensin IIJ A Goldberg, M S Bradnam, D J Kerr, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998

Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancerC V Christodoulou, D R Ferry, D W Fyfe, et al.

Pageof 22